Animal model of sclerotic skin induced by bleomycin: A clue to the pathogenesis of and therapy for scleroderma?

被引：25
|
作者：
Yamamoto, T [1 ]
机构：
[1] Tokyo Med & Dent Univ, Sch Med, Dept Dermatol, Bunkyo Ku, Tokyo 1138519, Japan
来源：
CLINICAL IMMUNOLOGY | 2002年 / 102卷 / 03期
关键词：
D O I：
10.1006/clim.2001.5169
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：209 / 216
页数：8
相关论文
共 50 条
  • [31] N-acetylcysteine attenuates subcutaneous administration of bleomycin-induced skin fibrosis and oxidative stress in a mouse model of scleroderma
    Zhou, C. -F.
    Yu, J. -F.
    Zhang, J. -X.
    Jiang, T.
    Xu, S. -H.
    Yu, Q. -Y.
    Zhu, Q. -X.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2013, 38 (04) : 403 - 409
  • [32] Development of a Skin-Humanized Model as a Novel Tool to Investigate the Pathogenesis of Scleroderma
    Escamez, M. J.
    Luchetti, M.
    Svegliati, S.
    Martinez, J.
    Duarte, B.
    de Almeida, E.
    Holguin, A.
    Retamosa, L.
    Illera, N.
    Garcia, E.
    Pevida, M.
    Llames, S. G.
    Larcher, F.
    Meana, A.
    Avvedimento, E. V.
    Gabrielli, A.
    del Rio, M.
    HUMAN GENE THERAPY, 2009, 20 (09) : 1057 - 1058
  • [33] Cyclosporine A-induced autoimmunity: an animal model for human scleroderma
    Damoiseaux, J
    van der Heijden, H
    van de Gaar, J
    Vriesman, PV
    JOURNAL OF EXPERIMENTAL ANIMAL SCIENCE, 2000, 41 (1-2) : 22 - 26
  • [34] Tumor necrosis factor-α processing inhibitor-1 inhibits skin fibrosis in a bleomycin-induced murine model of scleroderma
    Terao, Mika
    Murota, Hiroyuki
    Kitaba, Shun
    Katayama, Ichiro
    EXPERIMENTAL DERMATOLOGY, 2010, 19 (01) : 38 - 43
  • [35] Adenosine A2A Receptor Blockade or Deletion Diminishes Fibrocyte Accumulation in the Skin in a Murine Model of Scleroderma, Bleomycin-induced Fibrosis
    Katebi, Majid
    Fernandez, Patricia
    Chan, Edwin S. L.
    Cronstein, Bruce N.
    INFLAMMATION, 2008, 31 (05) : 299 - 303
  • [36] Nimbolide ameliorates fibrosis and inflammation in experimental murine model of bleomycin-induced scleroderma
    Diddi, Snehalatha
    Bale, Swarna
    Pulivendala, Gauthami
    Godugu, Chandraiah
    INFLAMMOPHARMACOLOGY, 2019, 27 (01) : 139 - 149
  • [37] Characterization of bleomycin induced skin and lung fibrosis mouse model
    Hamang, M.
    Xu, D.
    Lucchesi, J.
    Buckman, C.
    Mc Entire, J.
    Shaikh, M.
    Yu, A.
    Whitesell, C.
    Campbell, T.
    Thirunavukkarasu, K.
    Ma, Y. L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (09) : B25 - B25
  • [38] Immunomodulating role of the JAKs inhibitor tofacitinib in a mouse model of bleomycin-induced scleroderma
    Aung, Wah Wah
    Wang, Chenyang
    Xibei, Jia
    Horii, Motoki
    Mizumaki, Kie
    Kano, Miyu
    Okamura, Ai
    Kobayashi, Tadahiro
    Matsushita, Takashi
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2021, 101 (03) : 174 - 184
  • [39] Adenosine A2A Receptor Blockade or Deletion Diminishes Fibrocyte Accumulation in the Skin in a Murine Model of Scleroderma, Bleomycin-induced Fibrosis
    Majid Katebi
    Patricia Fernandez
    Edwin S. L. Chan
    Bruce N. Cronstein
    Inflammation, 2008, 31 : 299 - 303
  • [40] Pyroptosis executor gasdermin D plays a key role in scleroderma and bleomycin-induced skin fibrosis
    Yang, Huan
    Shi, Yanqiang
    Liu, Huiting
    Lin, Feiyan
    Qiu, Biying
    Feng, Qinglan
    Wang, Yu
    Yang, Bin
    CELL DEATH DISCOVERY, 2022, 8 (01)
12345